OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Clinical trials for OLIGOMETASTATIC PROSTATE CANCER (OMPC) explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC PROSTATE CANCER (OMPC) trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC PROSTATE CANCER (OMPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack targets stubborn prostate cancer spots
Disease control Recruiting nowThis early-stage study is testing a three-part treatment for prostate cancer that has returned and spread to a few spots after surgery. Participants receive an experimental DNA vaccine designed to teach the immune system to attack cancer, combined with an immunotherapy drug (nivo…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Targeted radiation zaps early prostate cancer spread, aims to delay harsh hormone therapy
Disease control Recruiting nowThis study is for men whose prostate cancer has returned and spread to a few locations after initial treatment. It aims to see if a targeted radiation drug (lutetium vipivotide tetraxetan) can better control the cancer and delay the need for hormone therapy compared to just monit…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC